Beacon Hill Medical Pharmacy, P.C.
Complete recall history across all FDA and CPSC categories, 86 total recalls
Beacon Hill Medical Pharmacy, P.C. appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.
Drug Recalls (86)
FDA drug safety enforcement actions by Beacon Hill Medical Pharmacy, P.C.. Showing most recent 50.
| Date | Product | Reason | Class |
|---|---|---|---|
| Jul 26, 2013 | B-12 REJUV 25 MG/ML INJECTABLE, all configurations, FOR INTRAVENO AND SQ USE ... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | SODIUM BICARBONATE PF 8.4% INJECTABLE, all presentations, FOR INTRAVENO AND S... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | SODIUM PHOSPHATE MONOBASIC/WATER FOR INJECTION 10%, all presentations, FOR IN... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | EDETATE DISODIUM 150 MG/ML INJECTABLE, all presentations, FOR INTRAVENO AND ... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | ESTRADIOL CYPIONATE 5, 10, 40 MG/ML OIL INJ SOLN, all configuration, FOR INTR... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | MIC-CARN MAX 15/100/50/1 MG/ML INJECTABLE, all presentations, FOR INTRAVENO a... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | DEXPANTHENOL 250 MG/ML INJECTABLE, all presentations, FOR INTRAVENO AND SQ U... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | HYALURONIDASE 150 U/ML and 200 U/ML INJECTABLE, all presentations, FOR INTR... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | DUAL-TESTOSTERONE 20, 50, 100, 150, 200 MG/ML OIL INJ SOLN, all presentations... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | SERMORELIN ACETATE 10 MG INJECTABLE, all presentations, FOR INTRAVENO AND SQ ... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | PYRIDOXINE HCL P/F 100 MG/ML INJECTABLE, all presentations, FOR INTRAVENO AN... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | VITAMIN B-COMPLEX INJECTABLE, VITAMIN B-COMPLEX SL SOLN and VITAMIN B-COMPLEX... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | ASCORBIC ACID (CORN SOURCE) 500 MG/ML INJECTABLE, all configurations, FOR INT... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | GLYCINE 50 MG/ML INJECTABLE, all presentations, FOR INTRAVENO and SQ USE ONLY... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | NALTREXONE 1 MG/ML INJECTABLE and 200 MG/ML INJECTABLE, all presentations, FO... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | MAGNESIUM SULFATE 50% INJECTABLE, all presentations, FOR INTRAVENO and SQ USE... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | SODIUM PHOSPHATE DIBASIC/WATER FOR INJECTION 10%, all presentations, FOR INTR... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | METHYLCOBALAMIN 1 mg/ml, 5 mg/ml, 10 mg/ml, 25 mg/ml and METHYLCOBALAMIN (PF... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | CHROMIUM 4 MCG/ML INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONL... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | GLUTATHIONE/METHYL/LIDO 100/25/20 MG/ML INJ SOLN and GLUTATHIONE/METHYL/LIDO... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | MANGANESE SULFATE 0.1 MG/ML INJECTABLE, all configurations, FOR INTRAVENO AN... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | GLUTAMINE 100 MG/ML INJ SOLN, all presentations, FOR INTRAVENO and SQ USE ONL... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | NANDROLONE DECANOATE 100 MG/ML and 200 MG/ML OIL INJ SOLN, all presentations,... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | LIPOIC ACID 100 MG/ML and 200 MG/ML INJECTABLE, all presentations, FOR INTRAV... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | L-TRYPTOPHAN 300 MG/ML INJECTABLE, all presentations, FOR INTRAVENO and SQ US... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | ARGININE (R-GENE) 100 MG/ML INJECTABLE, all presentations, FOR INTRAVENO AND ... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | TESTOSTERONE HYPOALLERGENIC 200 MG/ML INJECTABLE and TESTOSTERONE AQUEOUS 100... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | MIC-CARN + B6/B12/LIDOCAINE 25/50/50/175MCG/1/0.1MG/ML INJECTABLE, all presen... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | SELENIUM 400 MCG/ML INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | ESTRIOL 5 MG/ML OIL INJ SOLN, all presentations, FOR INTRAVENO AND SQ USE ONL... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | SODIUM HYDROXIDE 10% (W/V)/WATER FOR INJECTION, all presentations, FOR INTRAV... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | CYANOCOBALAMIN 1000 MCG/ML INJ SOLN, all presentations, FOR INTRAVENO AND SQ... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | B-COMPLEX/LIDO/B-12, 25MG/ML INJECTABLE, all presentations, FOR INTRAVENO AND... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | HYDROXYPROGESTERONE CAPROATE 250 MG/ML OIL INJ SOLN, all presentations, FOR ... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | PUMICE/LIDOCAINE HCL 1.5%/1% INJ SUSP, all presentations, FOR INTRAVENO AND S... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | ALPROSTADIL 100 MCG/ML INJ SOLN, all sizes, FOR INTRAVENO AND SQ USE ONLY, ST... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | H.C.G. (COMPOUNDED), 5,000, 8, 000, 10,000, 11,000 and 12,000 UNIT VIALS INJE... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | TESTOSTERONE CYPIONATE 100 MG/ML, 200 MG/ML, 20 MG/ML OIL INJ SOLN, all conf... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | POTASSIUM CHLORIDE 2 MEQ/ML INJECTABLE, all presentations, FOR INTRAVENO AND ... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | BI-MIX PHENTOLAMINE/PAPAVERINE 0.5 MG/30 MG/ML and BI-MIX PHENTOLAMINE/PAPAVE... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | TRIPLE-TESTOSTERONE 250 MG/ML OIL INJ SOLN and TRIPLE-TESTOSTERONE 200 MG/ML ... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | TESTOSTERONE PROPIONATE 100 MG/ML OIL INJ SOLN, all configuration, FOR INTRAV... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | VITAMIN D 50,000 I.U./ML INJECTABLE, all configurations, FOR INTRAVENO AND SQ... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | B-COMPLEX/LIDOCAINE 2% INJECTION, all presentations, FOR INTRAVENO AND SQ USE... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | DMSO 50% INJ 50 ML VIAL INJECTABLE, all presentations, FOR INTRAVENO AND SQ U... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | DEXTROSE PF 50% INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY,... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | HYDROGEN PEROXIDE 3% INJECTABLE, all presentations, FOR INTRAVENO and SQ USE ... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | ACETYLCYSTEINE 100 MG/ML INJ SOLN, all presentations, FOR INTRAVENO AND SQ U... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | FUROSEMIDE 10 MG/ML INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE O... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
| Jul 26, 2013 | ALPROSTADIL, 50 MCG/ML INJ SOLN, all presentations, FOR INTRAVENO AND SQ USE ... | Lack of Assurance of Sterility; FDA inspectional findings resulted in concern... | Class II |
Frequently Asked Questions
A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.
Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.
The FDA classifies recalls into three categories. Class I is the most serious, there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious, the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.
Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.
Explore More Recalls
Search recalls by category, state, reason, or firm across all our databases.